Publications

Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The Emperor-Preserved Trial

AuthID
P-00Y-Y49

Author(s)

Böhm, M

Butler, J

Krawczyk, M

Mahfoud, F

Haring, B

Filippatos, G

Ferreira, JP

Pocock, SJ

Brueckmann, M

Ofstad, AP

Schüler, E

Wanner, C

Verma, S

Packer, M

Anker, SD

Group Author(s)

behalf EMPEROR

Document Type

Article

Year published

2023

Published

in EUROPEAN JOURNAL OF HEART FAILURE, ISSN: 1388-9842

Volume: 25, Issue: 8, Pages: 1375-1383 (9)

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1002/ejhf.2922

Pubmed: 37278451

Wos: WOS:001033249800001

Source Identifiers

ISSN: 1388-9842

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The Emperor-Preserved Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The Emperor-Preserved Trial

Useful Links

Get Help